JAGX ▲ +1.9% - Jaguar Health, Inc.
$JAGX - Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
21-OCT-2026 09:00 AM ET
Share this post
More filings for $JAGX
JAGX ▼ -2.6% - Jaguar Health, Inc.Oct 14, 2026JAGX ▼ -10.1% - Jaguar Health, Inc.Oct 14, 2026JAGX ▼ -5.8% - Jaguar Health, Inc.Oct 13, 2026JAGX ▲ +35.9% - Jaguar Health, Inc.Oct 6, 2026JAGX ▼ -6.6% - Jaguar Health, Inc.Oct 3, 2026JAGX ▼ -0.2% - Jaguar Health, Inc.Sep 29, 2026
View full $JAGX filing history →💬 Comments
Loading comments…
Leave a comment